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Alcohol dehydrogenases (ADHs) are widely used to catalyze the 
reduction and oxidation of carbonyl groups and alcohols, 
respectively. Recently, these oxidorreductases have found 
important applications in both academia and industry for the 
production of pharmaceuticals, fragrances and high added value 
derivatives.[1] Although the stereoselective bioreduction of 
prochiral ketones is a very attractive transformation for organic 
chemists, the oxidation of alcohols is less appealing because in 
most of the cases the chirality is lost. Thus, there are a limited 
number of biocatalytic examples reporting on the oxidation of 
diols to the corresponding lactones.[2] Remarkably, 1,4-butanediol 
has been recently used as an irreversible cosubstrate for redox 
biocatalysis leading to -butyrolactone as a thermodynamically 
stable and kinetically inert coproduct.[3] In this context, the 
biocatalytic enantioselective oxidation of diols,[4] and, in particular 
meso and prochiral diols, has been scarcely investigated. 
Conceptually, this approach is a powerful strategy for the 
preparation of optically active compounds since the substrate 
loses one or more elements of symmetry.[5] To the best of our 
knowledge, only a few examples in the literature apart from early 
examples by Jones and co-workers deal with the enzymatic 
desymmetrization of prochiral 1,5-pentanediols through oxidative 
processes.[4a,c,e] 
Lactones are important compounds because of their structural 
implications as basic chemicals but also they are relevant building 
blocks found in natural products.[6] With the growing demand for 
enantiomerically pure synthons, the biocatalyzed preparation of 
chiral lactones remains a challenging goal and different 
(chemo)enzymatic routes have been successfully applied making 
use of lipase-mediated hydrolysis of carboxylic acid derivatives,[7] 
Baeyer-Villiger biooxidations of the corresponding cyclic 
ketones,[8] or ADH-catalyzed bioreduction of ketones.[9] 
Herein, we report an asymmetric approach for the synthesis of 
enantioenriched lactones based on the desymmetrization of the 
corresponding 3-arylpentane-1,5-diols. Enantioselective oxidation 
of prochiral diols for the preparation of these relevent compounds 
using ADHs could represent an interesting alternative to the 
commonly employed protocols. 
In a first set of experiments, we screened a panel of ADHs in 
the one-pot oxidation of 3-phenylpentane-1,5-diol as model 
substrate (1a, Table 1) to prepare the corresponding 
enantioenriched -valerolactone 3a (Table 1). Among them, 
HLADH showed the highest activity (see SI for details) and 
therefore it was selected for further optimization of the biocatalytic 
process. 
Table 1. Optimization of the  enzymatic reaction of 1a 
 
Entry[a] pH cosolvent c (%)[b] (S)-3a ee(%)[c] 
1[d] 9 - 52 (1:1.8) 48 
2 7.5 - 100 (1:16) 49 
3 6.5 - 80 (1:4) 50 
4 9 - 66 (1: 5.2) 38 
5[e] 7.5 - 70 (0:1) 44 
6[f] 7.5 - 46 (1:3) 50 
7[g] 7.5 - 34 (1:1) 45 
8 7.5 2% THF 84 (1:5.4) 54 
9 7.5 5% THF 72 (1:3) 64 
10 7.5 7% THF 61 (1:2) 74 
11 7.5 2% CH3CN 73 (1:3.2) 50 
12 7.5 7% CH3CN 62 (1:2.6) 60 
[a] Reactions were carried out using 25 mM concentration of 1a, 0.84 mM of 
NAD+, 2 U of HLADH and the recycling system in Tris buffer for 72 h at 30 ºC 
unless noted. [b] Conversion was determined by GC considering the 
formation of hemiacetal 2a and lactone 3a, which ratio appears in 
parentheses. [c] Enantiomeric excesses of 3a were determined by HPLC. [d] 
FMN was used as recycing system. Reaction performed at [e] 37 ºC, [f] 20 
ºC and [g] 4 ºC. 
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Formation of the valerolactone occurs by desymmetrization of 1a, 
which is oxidized generating an unstable hydroxy aldehyde that 
cyclised affording the corresponding hemiacetal (2a). The 
subsequent reoxidation of the latter gave access to the stable 
lactone 3a.[10] Based on these initial results and in order to use 
catalytic amounts of NAD+ cofactor, we next attempted the 
enantioselective oxidation of diol 1a by incubation with HLADH 
using flavin mononucleotide (FMN) as recycling system.[4a] 
Reaction was monitored by GC observing a slow oxidation of diol 
1a. Under the above mentioned conditions, a mixture of 
hemiacetal 2a and lactone 3a was observed in a ratio 1:1.8, 
yielding the lactone 3a with a modest 48% ee after 72 h (Table 1, 
entry 1). It is worth mentioning that previously reported 
enantiomeric excess for the desymmetrization of 1a was 21% 
ee.[4a] The biotransformation proceeded with stereoselectivity 
towards the pro-S hydroxy group, and preferentially, after 
reoxidation to the (S)-lactone. 
In order to improve the conversion values towards the lactone, 
we explored other recycling systems and reaction conditions. 
Firstly, the addition of acetaldehyde to the reaction mixture was 
attempted. Unfortunately, no reaction was observed probably due 
to inhibition issues. Based on this unsuccessful result with the 
coupled substrate approach, L-lactate dehydrogenase (LDH) was 
used. This enzyme catalyzes the reduction of pyruvate to lactate 
with the concomitant oxidation of NADH to regenerate NAD+.[11] 
Remarkably, this regeneration system led to total conversion of 
the process, yielding the (S)-lactone in moderate enantiomeric 
excess after 72 h (Table 1, entry 2). The experimental results 
clearly indicate that the enantioselection in the 1a2a step is the 
most important contribution. The enantiomeric excess of final 
lactone 3a remains mainly unaltered when the conversion values 
are between 50% and 100% (see SI for detailed time course 
study). 
At this point, different parameters were investigated in order 
to enhance the ee of this biotransformation. As expected, a 
change in the pH of the reaction drastically affected the yield of 
the process (Table 1, entries 3 and 4) without improvement of the 
ee and in detriment of the 2a:3a ratio. Next, the effect of the 
temperature was studied, and although an increase of the 
temperature favoured the formation of the termodynamically 
stable lactone 3a (note that hemiacetal 2a was not detected at 37 
ºC, entry 5), the conversion of the process drastically decreased. 
Yet, when the reaction was carried out at lower temperatures (20 
ºC and 4 ºC, entries 6 and 7), only lower conversions were 
observed indicating that these parameters are not tuneable to 
achieve better ee values. 
Motivated by the fact that oxidoreductases can work in organic 
solvents with interesting changes in their properties,[12] a 
percentage of cosolvent with respect to the buffer solution was 
added to the reaction mixture (Table 1, entries 8-12). Gratifyingly, 
a significant improvement in the enantioselectivity was observed. 
The best results in terms of conversion and enantiomeric excess 
were obtained when THF was used (Table 1, entries 8, 9 and 10) 
observing a 74% ee when 7% of THF was present. However, we 
should mention here that the yield of 3a dropped considerably in 
the lattest case. Percentages of cosolvent higher than 15% 
inhibited the oxidation reaction (data not shown). Solvent 
engineering studies demonstrated that when acetonitrile was 
used as the cosolvent, conversions were slighly lower than with 
THF (Table 1, entries 11 and 12). Moreover, the addition of a 
non-miscible cosolvent such as hexane allowed the addition of 
higher percentages of cosolvent, finding similar conversions and 
ee values than in aqueous medium (data not shown). 
We also extended this methodology to other 3-arylpentane-1,5-
diols 1b-g[13] (Table 2) in order to study the effect of the pattern 
substitution in the aromatic ring on the lactonization reaction. 
From the results in Table 2, it becomes clear that the introduction 
of a group in the aromatic ring at the para- position (1b and 1c) 
led to a slight improvement of the ee (Table 2, entries 3 and 5). 
This could be explained by additional interactions in the active 
site of the HLADH. Nevertheless, the conversions for the 
oxidation of these substrates dropped. 
Table 2. Enantioselective preparation of -valerolactones 3ag: effect of the 
substituent position and cosolvent 
 
Entry[a] R THF(%) c (%)[b] (S)-3a–g ee(%)[c] 
1 C6H5 (a) ---- 100 (1:9) 52 
2 C6H5 (a) 7 61 (1:2.5) 74 
3 4-MeO-C6H4 (b) ---- 92 (1:17) 60 
4 4-MeO-C6H4 (b) 7 55 (1:3) 68 
5 4-F-C6H4 (c) ---- 72 (1:2.6) 65 
6 4-F-C6H4  (c) 7 39 (2:1) 76 
7 3-MeO-C6H4 (d) ---- 82 (1:9) 40 
8 3-MeO-C6H4 (d) 7 43 (1:1.8) 53 
9 3-F-C6H4 (e) ---- 71 (1:3.5) 52 
10 3-F-C6H4 (e) 7 31 (1:0.8) 75 
11 2-MeO-C6H4 (f) ---- 62 (1:15) 92 
12 2-MeO-C6H4 (f) 7 21 (1:3) 97 
13 2-F-C6H4 (g) ---- 76 (1:12) 50 
14 2-F-C6H4 (g) 7 32 (1:2) 55 
[a] Reactions were carried out using 25 mM concentration of substrates 1a-
g, 0.84 mM of NAD+,  68 mM of pyruvate, LDH and 2 U of HLADH in Tris 
buffer pH= 7.5 at 30 ºC during 72 h. [b] Conversion values were determined 
by GC considering the formation of the corresponding hemiacetal and 
lactone, which ratio appears in parentheses. [c] Enantiomeric excesses of 
lactones were determined by HPLC. 
We next turned our attention to diols 1d-g possesing 
substituents closer to the prochiral center (meta- and ortho- 
positions). We can observe that 3-(m-methoxyphenyl)pentanediol 
(1d) reacts slower in comparison to the corresponding para- 
substituted diol (1b), the ee being also lower (Table 2, entry 7). 
This outcome may suggest that the substrate binds less efficiently 
in the active site. The same tendency was observed with 1e 
(Table 2, entry 9). Moreover, when the methoxy group was 
placed at the ortho- position (1f) it had a remarkable effect on the 
enantioselectivity observing a 92% ee (Table 2, entry 11). In light 
of these results, we can hypothesize that the enantioselectivity of 
the process is not simply influenced by the presence of a 
substituent but also by its position that may interact with residues 
in the HLADH active site. However, for the substrate 1g 
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containing a fluorine atom in ortho-position, the ee dropped again 
probably due to the small size of the substituent (Table 2, entry 
13).  
In order to further rationalize the relation between the diol 
structure and the enantioselectivity, docking studies were 
performed on substrates 1a, 1g and 1f.14 For the sake of 
simplicity, we only focused on the desymmetrization process. It 
was found that whereas compound 1a and 1g form a E-S 
complex where the pro-R and pro-S conformations resulted in the 
same structure, compound 1f shows important diferences in both 
conformers. In particular an intramolecular hydrogen bond 
interaction is observed for the pro-S conformation (see Figure 1 
and SI for more details), supporting the experimental 
observations. Furthermore, we would like to highlight that as a 
general trend although conversion values decreased considerably 
when adding THF, the optical purities for the final valerolactones 
improved in all cases (Table 2, entries 2, 4, 6, 8, 10, 12 and 14). 
 
Fig 1. Substrate 1f in complex with HLADH. Black and cyan ligands are 
precursors of the R and S enantiomers, respectively (left) and intramolecular 
hydrogen bond interaction for the pro-S enantiomer (right). 
Overall, the versatility of desymmetrization processes have 
been demonstrated over a series of 3-aryl-pentane-1,5-diols 
through their selective oxidation using HLADH, leading to 
interesting lactones in good to excellent optical purities. This 
method expands the enzyme toolbox, as hydrolases were 
previously employed for the highly stereoselective 
desymmetrizarion of similar diols by means of acylation 
reactions,13 but also providing straightforward access to related 
lactones via hydrolytic processes of diesters, followed by 
chemical intramolecular cyclization.7 Our study shows that 
HLADH can be also applied for desymmetrization oxidation 
reactions of bulky diols to prepare enantioenriched lactones 
expanding the substrate scope hitherto reported.4a Optical 
purities can be tuned by adding organic cosolvents, where THF 
has shown a beneficial effect in terms of enantiodiscrimination 
while aqueous systems lead to the isolation of the lactones in 
higher yields. The synthesis of substituted diols has allowed the 
evaluation of a certain structure-activity relationship in the active 
site of HLADH. We are currently investigating further 
opportunities in this area, considering new target substrates and 
focusing on the improvement of the conversion values. 
Experimental Section 
General procedure for the enantioselective preparation of 
valerolactones 3a-g. In a typical experiment, a diol 1a-g (25 
mM) was suspended in Tris buffer (50 mM, pH 7.5, 0.5 mL) and 
treated with NAD+ (50 L, 10 mM stock, 0.84 mM), sodium 
pyruvate (40 L, 1 M stock, 68 mM) and LDH (2 U). This mixture 
was shaken for 5 min and, finally, HLADH was added (2 U). The 
mixture was shaken at 250 rpm in a rotatory shaker at 30 ºC, 
extracted with EtOAc (2 x 0.5 mL), dried over Na2SO4 and 
analyzed by GC in order to determine the conversion value. 
HPLC analyses were carried out to determine the enantiomeric 
excesses. Control experiments in the absence of enzyme were 
performed for all substrates, not observing oxidation reaction after 
long periods of time. 
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Horse liver alcohol dehydrogenase 
has been found to be a versatile 
biocatalyst for the desymmetrization 
of 3-arylpentane-1,5-diols based on 
a two-step one-pot oxidation. The 
catalytic performance of HLADH 
has been studied using several 
cofactor regeneration systems and 
cosolvents. Docking studies has 
revealed the pattern substitution 
importance in the selectivity and 
activity of this biotransformation. 
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